MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice

Takahiro Horie(Kyoto University), Tomohiro Nishino(Kyoto University), Osamu Baba(Kyoto University), Yasuhide Kuwabara(Kyoto University), Tetsushi Nakao(Kyoto University), Masataka Nishiga(Kyoto University), Shunsuke Usami(Kyoto University), Masayasu Izuhara(Kyoto University), Naoya Sowa(Kyoto University), Naoya Yahagi(University of Tsukuba), Hitoshi Shimano(University of Tsukuba), Shigenobu Matsumura(Kyoto University), Kazuo Inoue(Kyoto University), Hiroyuki Marusawa(Kyoto University), Tomoyuki Nakamura(Kansai Medical University), Koji Hasegawa(Kyoto Medical Center), Noriaki Kume(Kobe Gakuin University), Masayuki Yokode(Kyoto University), Toru Kita(Kobe City Medical Center General Hospital), Takeshi Kimura(Kyoto University), Koh Ono(Kyoto University)
Nature Communications
December 3, 2013
Cited by 225Open Access
Full Text

Abstract

MicroRNAs (miRs) are small non-protein-coding RNAs that bind to specific mRNAs and inhibit translation or promote mRNA degradation. Recent reports have indicated that miR-33, which is located within the intron of sterol regulatory element-binding protein (SREBP) 2, controls cholesterol homoeostasis and may be a potential therapeutic target for the treatment of atherosclerosis. Here we show that deletion of miR-33 results in marked worsening of high-fat diet-induced obesity and liver steatosis. Using miR-33(-/-)Srebf1(+/-) mice, we demonstrate that SREBP-1 is a target of miR-33 and that the mechanisms leading to obesity and liver steatosis in miR-33(-/-) mice involve enhanced expression of SREBP-1. These results elucidate a novel interaction between SREBP-1 and SREBP-2 mediated by miR-33 in vivo.


Related Papers

No related papers found

Powered by citation graph analysis